GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

mepolizumab   Click here for help

GtoPdb Ligand ID: 7685

Synonyms: Nucala® | SB-240563
Approved drug Immunopharmacology Ligand
mepolizumab is an approved drug (EMA & FDA (2015))
Compound class: Antibody
Comment: The Nucala® brand of mepolizumab is a humanized interleukin-5 antagonist monoclonal antibody produced by recombinant DNA technology in Chinese hamster ovary cells.
IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: mepolizumab

Classification Click here for help
Compound class Antibody
Approved drug? Yes. China NMPA (2024)  |  US FDA (2015)  |  EU EMA (2015)
International Nonproprietary Names Click here for help
INN number INN
7876 mepolizumab
Synonyms Click here for help
Nucala® | SB-240563
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 87
Other databases
GtoPdb PubChem SID 223366020
Search PubMed clinical trials mepolizumab
Search PubMed titles mepolizumab
Search PubMed titles/abstracts mepolizumab
Wikipedia Mepolizumab